Prevalence of Substance Use and Related Factors in Patients Seeking Treatment for Obesity

Prevalence of Substance Use and Related Factors in Patients Seeking Treatment for Obesity

Authors

  • İrem Yaluğ Kocaeli Üniversitesi Tıp Fak. Psikiyatri Anabilim Dalı
  • Mine Özmen İ.Ü. Cerrahpaşa Tıp Fak. İç Hastalıkları Anabilim Dalı
  • Ali Evren Tufan Kocaeli Üniv. Tıp Fak. Çocuk ve Ergen Psikiyatrisi Anabilim Dalı
  • Volkan Yumuk İ.Ü. Cerrahpaşa Tıp Fak. İç Hastalıkları Anabilim Dalı

Keywords:

obesity, dopamine, nicotine, alcohol, body mass index

Abstract

Objective: Obese individuals who self present for treatment are commonly found to have associated psychopathology. This study is designed to clarify the prevalence and predictors of substance use in an obese population undergoing treatment in a university hospital.
Method: This is a cross sectional study which evaluated 169 patients being followed for treatment of obesity in Istanbul University Cerrahpasa Medical Faculty, Department of Endocrinology, for comorbid psychopathology, by means of structured interviews (SCID I and II). Patients with Body Mass Index (BMI) >25.0 are defined as obese and those with BMI between 25.0-29.9 are divided as stage I, the remainder being stage II. Data were analysed with descriptive statistics, binomial regression analysis and chi square test. A difference at the level of P<0.05 was accepted as statistically significant.
Results: The ratios of smoking and alcohol use in BMI Stage I and II groups were 30 % and 10% and 35.8 % and 17.5 % respectively. It did not differ significantly in between groups but was significanlty higher in male patients.
Discussion: Our findings clearly indicate that there is a high prevalence of substance use in obese patients, especially for those severely overweight and males. These findings underlie the importance of evaluation for substance use in addition to the medical examination in obese patients.

References

Lee L, Shapiro CM. Psychological manifestations of obesity. J Psychosom Res 2003; 55: 477-479

Brownell KD, Wadden TA. Obesity. Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. Sadock BJ, Sadock VA (Eds). 7. Baskı, Philedelphia: Lippincott, Williams and Wilkins, 2000 :1787-1797

Shuckit MA. Alcohol related disorders. Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. Sadock BJ, Sadock VA (Eds). 7. Baskı, Philadelphia, Lippincott Williams and Wilkins, 2000: 953-970

Hughes JR. Nicotine related disorders. Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. Sadock BJ, Sadock VA (Eds). 7. Baskı, Philadelphia: Lippincott, Williams and Wilkins, 2000: 1033-1038

Chyou P-H, Burchfiel CM, Yano K, Sharp DS, Rodriguez BL, Curb JD, Nomura AMY. Obesity, alcohol consumption, smoking, and mortality. Ann Epidemiol, 1997; 7: 311-317

Noble EP. Phenotypic expression of the D2 dopamine receptor: a reinforcement or reward gene. Biol Psychiatry 1997; 42 (Suppl): 295S

Noble EP. Addiction and its reward process through polymorphisms of the D2 Dopamine receptor gene: a review. Eur Psychiatry; 2000; 15: 79-89

Çorapçıoğlu A, Aydemir O, Yıldız M, ve ark. DSM-IV Eksen I Bozuklukları (SCID-I) İçin Yapılandırılmış Klinik Görüşme, Klinik Versiyonun Türkçe geçerlilik ve güvenilirliği. İlaç ve Tedavi Dergisi; 1999; 12: 233-236

Akdemir A, Örsel SD, Dağ İ ve ark. Hamilton Depresyon Derecelendirme Ölçeği (HDDÖ)’nin geçerliği-güvenirliği ve klinikte kullanımı. Psikiyatri Psikoloji Psikofarmakoloji Dergisi, 1996; 4: 251-259

Caterson ID, Broom J. Obesitenin tanımı ,değerlendirilmesiveepidemiyolojisi.Obesite resimli cep kılavuzu. M. Kahramanoğlu (Çev) İstanbul, Ant Yayınevi, 2003; 19-20.

Noble Ep, Fitch RJ, Ritchie T ve ark. The D2 dopamine receptor gene: obesity, smoking and mood. Obesity Assessment. St. Jeor ST (Ed). New York, Chapman and Hall; 1997: 522-533

Comings DE, Flanagan SD, Dietz G, ve ark. The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem Med Metab Biol 1993; 50: 176-185

Noble EP, Noble RE, Ritchie T ve ark. D2 dopamine receptor gene and obesity. Int J Eating Disord 1994; 15: 205-217

Comings DE, Gade R, Macmurray JP ve ark. Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Mol Psychiatry 1996; 1: 325,335

Palme G, Palme J. Personality characteristics of females seeking treatment for obesity, bulimia nervosa and alcoholic disorders. Pers Individ Dif 1999¸p;26: 255-263

Yasuno F, Suhara T, Suda Y, ve ark. Relation among dopamine D2 receptor binding, obesity abd personality in normal human subjects. Neurosci Lett 2001; 300: 59-61

Published

2005-04-01

How to Cite

1.
Yaluğ İrem, Özmen M, Tufan AE, Yumuk V. Prevalence of Substance Use and Related Factors in Patients Seeking Treatment for Obesity. J Depend [Internet]. 2005 Apr. 1 [cited 2025 Aug. 20];6(1):27-32. Available from: https://bagimlilik.akademisyen.net/index.php/bagimlilik/article/view/97

Issue

Section

Research Article
Loading...